About Careers MedBlog Contact us

Princess Margaret Cancer Center and Vall D'Hebron Institute of Oncology Partner to Advance Personalized Cancer Medicine

by Dr. Trupti Shirole on March 1, 2015 at 5:29 AM
Font : A-A+

 Princess Margaret Cancer Center and Vall D'Hebron Institute of Oncology Partner to Advance Personalized Cancer Medicine

Two internationally acclaimed cancer centers announced a partnership to accelerate academic and clinical research to advance personalized, targeted therapies against cancer. The partners, Princess Margaret Cancer Centre, University Health Network, Toronto and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, signed a Memorandum of Understanding (MOU) in Toronto establishing the principles and framework for their collaboration.

Signing on behalf of the Princess Margaret, Medical Director Dr. Mary Gospodarowicz said, "Our organizations share a common purpose and vision to pool our knowledge, broad spectrum of expertise and commitment to research to promote and disseminate best practices and innovation in cancer care globally. This is how we can to provide world-class cancer research and the best possible care to benefit patients well beyond the walls of our individual centers."


Signing on behalf of VHIO, Director Dr. Josep Tabernero said, "As two leading comprehensive cancer centers, we share several research strengths and synergies. VHIO's cancer science of excellence coupled with the Princess Margaret's expertise in the realm of cancer care diagnostics and therapeutics will undoubtedly represent an important forward step in advancing cancer research and developing more effective anti-cancer therapies."

Under the terms of the MOU, the two centers will exchange information about patient care and research, and education programs. They will also be sharing information about best practice in clinical research and clinical trials. Also, they will support innovation in cancer education and training programs by encouraging academic collaborations, promoting faculty visits and facilitating exchange visits among students and trainees.

Source: Medindia


Recommended Reading

Latest Cancer News

Exploring the Role of Neutrophils in Immunotherapy
Neutrophils, the blood cell types are mobilized to fight cancer if they are appropriately engaged.
How Can Mouse Avatars Help Treat Multiple Myeloma?
The mouse avatars created help study and develop personalized treatments against blood cancer - myeloma.
Why Is Time of Day Important in Cancer Diagnosis and Treatment?
Chronotherapy (the sleep-wake cycle) is observed as a valuable alternative treatment in cancer diagnosis and treatment.
How Do Neutrophils Impact Pancreatic Cancer Treatment Resistance?
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Princess Margaret Cancer Center and Vall D'Hebron Institute of Oncology Partner to Advance Personalized Cancer Medicine Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests